To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No Clinical Benefit of 12 Weeks of Daily Oral Colchicine vs Placebo for Hand Osteoarthritis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2021

No Clinical Benefit of 12 Weeks of Daily Oral Colchicine vs Placebo for Hand Osteoarthritis

Vol: 17| Issue: 1| Number:4| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)

Osteoarthritis Cartilage. 2021 Feb;29(2): 208-214.

Contributing Authors:
CR Davis Cd Ruediger KA Dyer S Lester SW Graf FPB Kroon SL Whittle CL Hill

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-four elderly patients diagnosed with hand osteoarthritis (OA) were randomized to receive 1 mg/day of colchicine (n=32) tablets or placebo tablets (n=32) for 12 weeks. The primary outcome of interest included hand pain measured using the Visual Analogue Scale (VAS), assessed at 6, 12 and 16 weeks follow-up. Secondary outcomes of interest included hand grip strength, tender and swollen joint (...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue